{"abstract":"This document extends the comment period on the Department's Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure proposed rule. The proposed rule would require providers of pharmacy benefit management services and affiliated providers of brokerage and consulting services to disclose information about their compensation to fiduciaries of self-insured group health plans subject to the Employee Retirement Income Security Act (ERISA), for purposes of ERISA's statutory prohibited transaction exemption for services arrangements. The proposed rule was published in the Federal Register on January 30, 2026, with a comment deadline of March 31, 2026. On February 3, 2026, the Consolidated Appropriations Act, 2026 amended ERISA to add several provisions relating to providers of pharmacy benefit management services. Consequently, the Department is extending the comment period for an additional 15 days, to April 15, 2026, to allow interested persons to address whether the rule should be adjusted due to these new statutory provisions.","action":"Proposed rule; extension of the comment period.","agencies":[{"raw_name":"DEPARTMENT OF LABOR","name":"Labor Department","id":271,"url":"https://www.federalregister.gov/agencies/labor-department","json_url":"https://www.federalregister.gov/api/v1/agencies/271","parent_id":null,"slug":"labor-department"},{"raw_name":"Employee Benefits Security Administration","name":"Employee Benefits Security Administration","id":131,"url":"https://www.federalregister.gov/agencies/employee-benefits-security-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/131","parent_id":271,"slug":"employee-benefits-security-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/03/02/2026-04084.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"2550","title":29}],"citation":"91 FR 10033","comment_url":null,"comments_close_on":"2026-04-15","correction_of":null,"corrections":[],"dates":"The comment period for the proposed rule published January 30, 2026, at 91 FR 4348, is extended. Comments should be received on or before April 15, 2026.","disposition_notes":null,"docket_ids":[],"dockets":[{"supporting_documents":[{"title":"PBM Transparency NPRM 100 Word Summary 1210-AB37","document_id":"EBSA-2026-0001-0002"}],"agency_name":"EBSA","documents":[{"comment_count":null,"comment_start_date":null,"updated_at":"2026-03-02T11:00:53.854-05:00","comment_url":"https://www.regulations.gov/commenton/EBSA-2026-0001-0017","allow_late_comments":false,"id":"EBSA-2026-0001-0017","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":1,"id":"EBSA-2026-0001","title":"Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure"}],"document_number":"2026-04084","effective_on":"2026-01-30","end_page":10034,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/03/02/2026-04084.xml","html_url":"https://www.federalregister.gov/documents/2026/03/02/2026-04084/improving-transparency-into-pharmacy-benefit-manager-fee-disclosure-extension-of-comment-period","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-04084?publication_date=2026-03-02","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-03-02/2026-04084/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":1133,"last_updated":"2026-05-19 06:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-02/pdf/2026-04084.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-04084.pdf?1772199921","publication_date":"2026-03-02","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/03/02/2026-04084.txt","regulation_id_number_info":{"1210-AB37":{"issue":"202504","html_url":"https://www.federalregister.gov/regulations/1210-AB37/improving-transparency-into-pharmacy-benefit-manager-fee-disclosure","title":"Improving Transparency into Pharmacy Benefit Manager Fee Disclosure","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202504&RIN=1210-AB37&operation=OPERATION_EXPORT_XML","priority_category":"Other Significant"}},"regulation_id_numbers":["1210-AB37"],"regulations_dot_gov_info":{"supporting_documents":[{"title":"PBM Transparency NPRM 100 Word Summary 1210-AB37","document_id":"EBSA-2026-0001-0002"}],"regulatory_plan":{"html_url":"https://www.federalregister.gov/regulations/1210-AB37/improving-transparency-into-pharmacy-benefit-manager-fee-disclosure","title":"Improving Transparency into Pharmacy Benefit Manager Fee Disclosure"},"comments_count":0,"agency_id":"EBSA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=EBSA-2026-0001","supporting_documents_count":1,"docket_id":"EBSA-2026-0001","document_id":"EBSA-2026-0001-0017","regulation_id_number":"1210-AB37","title":"Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure","checked_regulationsdotgov_at":"2026-03-03T18:55:04Z"},"regulations_dot_gov_url":null,"significant":true,"signing_date":null,"start_page":10033,"subtype":null,"title":"Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure; Extension of Comment Period","toc_doc":"Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure","toc_subject":null,"topics":[],"type":"Proposed Rule","volume":91}